实验动物与比较医学 ›› 2020, Vol. 40 ›› Issue (5): 449-.DOI: 10.3969/j.issn.1674-5817.2020.05.015

• 综述 • 上一篇    下一篇

肠道病毒71型致病机制及免疫反应研究进展

施梅言 , 陆彩霞 ,代解杰   

  1. 中国医学科学院/北京协和医学院医学生物学研究所树鼩种质资源中心,昆明 650118
  • 收稿日期:2020-03-23 出版日期:2020-10-15 发布日期:2020-11-19
  • 作者简介:施梅言(1994—), 女, 硕士研究生, 研究方向: 病原生物学。E-mail: 1758651731@qq.com
  • 基金资助:

    云南省科技人才和平台计划 (2017HC019,2018HB071); 

    云南省高层次卫生健康技术人才培养项目(D-2018026); 

    昆明市科技计划项目(2019-1-R24483)

Progress in Pathogenesis and Immune Response of Enterovirus 71#br#

SHI Meiyan, LU Caixia, DAI Jiejie   

  1. Tree Shrew Germplasm Resource Center, Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Kunming 650118, China
  • Received:2020-03-23 Online:2020-10-15 Published:2020-11-19

摘要: 肠道病毒71型(enterovirus 71,EV71)主要经由胃肠道或呼吸道传染人类,是引起手足口病的主要病原体之一,还能导致神经系统性疾病,如神经源性肺水肿,甚至死亡,严重威胁婴幼儿生命安全。虽然EV71的全病毒灭活疫苗已经上市,但其感染导致的并发症的致病机制及免疫反应尚未完全明确。本文对EV71的致病机制、免疫应答及免疫原性方面的动物实验研究进展进行综述,为深入研究EV71提供理论支持。    

关键词: 肠道病毒71型, 致病机制, 动物实验, 免疫反应

Abstract: Enterovirus 71 (EV71) mainly infects humans through the gastrointestinal or respiratory tracts, which is one of the main pathogens of hand, foot and mouth disease. It can also cause neurological diseases such as neurogenic pulmonary edema and even death, threatening the safety of infants and young children. Although the whole-virus inactivated vaccine of EV71 has been marketed, the pathogenesis and immune response of complications caused by its infection have not been fully clarified. This article reviews the pathogenesis, immune response and immunogenicity response of EV71, which will pave the way for further research on EV71. 


Key words: Enterovirus 71, Pathogenesis, Animal experiment, Immune response

中图分类号: